grant

Are calcium channel blockers associated with breast cancer? Assessing the impact of long-term use in large longitudinal cohorts

Also known as: Clinical Trials and Cohort Studies

Funded by National Health and Medical Research Council
Managed by Curtin University
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2014896]

Funding Amount $1,107,757.00

Full description Breast cancer is the commonest cancer in women. Calcium channel blockers (CCBs) are frequently used worldwide to treat high blood pressure. A link between use of CCBs and breast cancer has been proposed with mixed findings in North American, European and Asian women. No data exist for Australian women or across populations. Since 1 in 8 Australian women will be diagnosed with breast cancer by age 85 years, it is important to determine whether this risk is increased by the use of CCBs.

Chief Investigator Prof Rachael Moorin

Date Announced 2022-05-18T00:00:00

Sector University

Click to explore relationships graph
Help

Related Organisations

Spatial Coverage And Location

text: WA

Subjects
Health Services Research | Medical and Health Sciences | Public Health and Health Services | Public Health and Health Services Not Elsewhere Classified | breast cancer | data linkage | high blood pressure | longitudinal cohort study | pharmacoepidemiology |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA